34766565|t|Effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus: A retrospective study of a patient cohort.
34766565|a|ABSTRACT: Adrenocorticotropic hormone (ACTH) and cortisol reportedly play a role in glycemic control in patients with type 2 diabetes mellitus (T2DM); however, the underlying mechanism remains controversial. We retrospectively investigated the effect of tofogliflozin on serum ACTH and cortisol levels in elderly patients with T2DM.Patients received 20 mg tofogliflozin daily for 3 months. Serum ACTH and cortisol levels were measured at baseline, as well as after 1 month and 3 months of tofogliflozin therapy.Serum ACTH levels were significantly reduced 3 months after tofogliflozin treatment (P < .01). Additionally, serum cortisol levels were reduced 3 months after tofogliflozin treatment, demonstrating borderline significance (P = .05). The higher body mass index (BMI; >=25 kg/m2) group showed higher ACTH and cortisol levels than the lower BMI (<25 kg/m2) group, with borderline significance (P = .05). Renin levels were significantly increased 1 month after treatment (P < .05), maintaining serum aldosterone levels in parallel with the extracellular fluid.Our findings suggested that tofogliflozin decreased both serum ACTH and cortisol levels, with higher levels observed in the high BMI group. Tofogliflozin increased serum renin levels while maintaining serum aldosterone and extracellular fluid levels. Collectively, tofogliflozin could affect the hypothalamic-pituitary-adrenal pathway in patients with T2DM, especially in the low BMI group.
34766565	11	24	tofogliflozin	Chemical	MESH:C575086
34766565	28	55	adrenocorticotropic hormone	Gene	5443
34766565	57	62	renin	Gene	5972
34766565	67	78	aldosterone	Chemical	MESH:D000450
34766565	84	92	cortisol	Chemical	MESH:D006854
34766565	111	119	patients	Species	9606
34766565	125	142	diabetes mellitus	Disease	MESH:D003920
34766565	171	178	patient	Species	9606
34766565	197	224	Adrenocorticotropic hormone	Gene	5443
34766565	226	230	ACTH	Gene	5443
34766565	236	244	cortisol	Chemical	MESH:D006854
34766565	291	299	patients	Species	9606
34766565	305	329	type 2 diabetes mellitus	Disease	MESH:D003924
34766565	331	335	T2DM	Disease	MESH:D003924
34766565	441	454	tofogliflozin	Chemical	MESH:C575086
34766565	464	468	ACTH	Gene	5443
34766565	473	481	cortisol	Chemical	MESH:D006854
34766565	500	508	patients	Species	9606
34766565	514	527	T2DM.Patients	Disease	MESH:D003924
34766565	543	556	tofogliflozin	Chemical	MESH:C575086
34766565	583	587	ACTH	Gene	5443
34766565	592	600	cortisol	Chemical	MESH:D006854
34766565	676	689	tofogliflozin	Chemical	MESH:C575086
34766565	704	708	ACTH	Gene	5443
34766565	758	771	tofogliflozin	Chemical	MESH:C575086
34766565	813	821	cortisol	Chemical	MESH:D006854
34766565	857	870	tofogliflozin	Chemical	MESH:C575086
34766565	996	1000	ACTH	Gene	5443
34766565	1005	1013	cortisol	Chemical	MESH:D006854
34766565	1099	1104	Renin	Gene	5972
34766565	1194	1205	aldosterone	Chemical	MESH:D000450
34766565	1282	1295	tofogliflozin	Chemical	MESH:C575086
34766565	1317	1321	ACTH	Gene	5443
34766565	1326	1334	cortisol	Chemical	MESH:D006854
34766565	1394	1407	Tofogliflozin	Chemical	MESH:C575086
34766565	1424	1429	renin	Gene	5972
34766565	1461	1472	aldosterone	Chemical	MESH:D000450
34766565	1519	1532	tofogliflozin	Chemical	MESH:C575086
34766565	1592	1600	patients	Species	9606
34766565	1606	1610	T2DM	Disease	MESH:D003924
34766565	Positive_Correlation	MESH:C575086	5972
34766565	Negative_Correlation	MESH:C575086	5443
34766565	Negative_Correlation	MESH:C575086	MESH:D003920
34766565	Association	MESH:C575086	MESH:D000450
34766565	Negative_Correlation	MESH:C575086	MESH:D006854
34766565	Association	MESH:D006854	MESH:D003924
34766565	Negative_Correlation	MESH:C575086	MESH:D003924
34766565	Association	MESH:D003924	5443

